Quantitative Fluxomics of Circulating Metabolites.
TCA cycle
circulating metabolites
energy metabolism
in vivo flux quantification
isotope tracing
ketogenic diet
metabolic cycling
Journal
Cell metabolism
ISSN: 1932-7420
Titre abrégé: Cell Metab
Pays: United States
ID NLM: 101233170
Informations de publication
Date de publication:
06 10 2020
06 10 2020
Historique:
received:
04
02
2020
revised:
06
04
2020
accepted:
20
07
2020
pubmed:
14
8
2020
medline:
9
11
2021
entrez:
14
8
2020
Statut:
ppublish
Résumé
Mammalian organs are nourished by nutrients carried by the blood circulation. These nutrients originate from diet and internal stores, and can undergo various interconversions before their eventual use as tissue fuel. Here we develop isotope tracing, mass spectrometry, and mathematical analysis methods to determine the direct sources of circulating nutrients, their interconversion rates, and eventual tissue-specific contributions to TCA cycle metabolism. Experiments with fifteen nutrient tracers enabled extensive accounting for both circulatory metabolic cycles and tissue TCA inputs, across fed and fasted mice on either high-carbohydrate or ketogenic diet. We find that a majority of circulating carbon flux is carried by two major cycles: glucose-lactate and triglyceride-glycerol-fatty acid. Futile cycling through these pathways is prominent when dietary content of the associated nutrients is low, rendering internal metabolic activity robust to food choice. The presented in vivo flux quantification methods are broadly applicable to different physiological and disease states.
Identifiants
pubmed: 32791100
pii: S1550-4131(20)30371-5
doi: 10.1016/j.cmet.2020.07.013
pmc: PMC7544659
mid: NIHMS1621247
pii:
doi:
Substances chimiques
Fatty Acids
0
Triglycerides
0
Lactic Acid
33X04XA5AT
Glucose
IY9XDZ35W2
Glycerol
PDC6A3C0OX
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
676-688.e4Subventions
Organisme : NIH HHS
ID : S10 OD025098
Pays : United States
Organisme : NIDDK NIH HHS
ID : DP1 DK113643
Pays : United States
Organisme : NIDDK NIH HHS
ID : R00 DK117066
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA211437
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK019525
Pays : United States
Organisme : NIDDK NIH HHS
ID : F32 DK118856
Pays : United States
Organisme : NIDDK NIH HHS
ID : K99 DK117066
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests J.D.R. is a member of the Rutgers Cancer Institute of New Jersey and of the University of Pennsylvania Diabetes Research Center; a co-founder and stockholder in VL54, Sofro, and Raze Therapeutics; and advisor and stockholder in Agios Pharmaceuticals, Kadmon Pharmaceuticals, Bantam Pharmaceuticals, Colorado Research Partners, Rafael Pharmaceuticals, and L.E.A.F. Pharmaceuticals.
Références
Nature. 2018 Aug;560(7719):499-503
pubmed: 30051890
Proc Nutr Soc. 1995 Mar;54(1):39-47
pubmed: 7568264
Metabolism. 1973 Feb;22(2):179-207
pubmed: 4567003
Curr Treat Options Neurol. 2008 Nov;10(6):410-9
pubmed: 18990309
Am J Med. 1954 Apr;16(4):504-15
pubmed: 13148192
Am J Physiol Endocrinol Metab. 2010 Nov;299(5):E808-15
pubmed: 20807839
J Lipid Res. 2007 Feb;48(2):337-47
pubmed: 17088263
Exp Biol Med (Maywood). 2012 Dec;237(12):1369-78
pubmed: 23354395
Am J Physiol. 1994 Mar;266(3 Pt 1):E334-40
pubmed: 8166253
Gastroenterology. 2014 Mar;146(3):726-35
pubmed: 24316260
Trends Endocrinol Metab. 2014 Apr;25(4):168-77
pubmed: 24389130
Metab Eng. 2001 Jul;3(3):195-206
pubmed: 11461141
Clinics (Sao Paulo). 2014 Dec;69(10):699-705
pubmed: 25518023
J Ind Microbiol Biotechnol. 2015 Mar;42(3):317-25
pubmed: 25613286
JMIR Diabetes. 2017 Mar 07;2(1):e5
pubmed: 30291062
Mol Metab. 2013 Jul 08;2(3):306-13
pubmed: 24049742
Cell Rep. 2016 Oct 18;17(4):1037-1052
pubmed: 27760311
Cell Metab. 2019 Sep 3;30(3):594-606.e3
pubmed: 31257152
Biochem Soc Trans. 1983 Jan;11(1):52-6
pubmed: 6337886
Cell Metab. 2018 Sep 4;28(3):415-431.e4
pubmed: 30017356
Cell. 2018 Oct 4;175(2):502-513.e13
pubmed: 30245009
Am J Physiol Endocrinol Metab. 2015 Jul 15;309(2):E191-203
pubmed: 25991647
J Biol Chem. 2016 Jun 3;291(23):12161-70
pubmed: 27002151
J Clin Invest. 2000 Aug;106(4):473-81
pubmed: 10953022
J Inherit Metab Dis. 1996;19(4):470-7
pubmed: 8884571
Adv Exp Med Biol. 2009;645:301-6
pubmed: 19227486
Redox Biol. 2014;2:963-70
pubmed: 25460731
Metab Eng. 2017 Sep;43(Pt B):94-102
pubmed: 27667771
Cancer Prev Res (Phila). 2009 Jun;2(6):557-65
pubmed: 19470786
Nat Protoc. 2009;4(6):878-92
pubmed: 19478804
BMC Cancer. 2008 Apr 30;8:122
pubmed: 18447912
J Clin Invest. 2000 Jul;106(2):171-6
pubmed: 10903330
J Biol Chem. 2003 Aug 15;278(33):30413-6
pubmed: 12788931
Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1724-39
pubmed: 17299079
BMC Cancer. 2016 May 13;16:310
pubmed: 27178315
J Cereb Blood Flow Metab. 2013 Aug;33(8):1307-11
pubmed: 23736643
Nat Med. 2015 Feb;21(2):108-9
pubmed: 25654596
Front Neurosci. 2019 Jan 29;13:5
pubmed: 30760973
Nature. 2017 Nov 2;551(7678):115-118
pubmed: 29045397
Trends Cell Biol. 1995 Nov;5(11):424-8
pubmed: 14732047